| 1 |
Huo L, Yu Y. The impact of the self-recognition ability and physical quality on coupled negative information-behavior-epidemic dynamics in multiplex networks. Chaos Solitons Fractals 2023;169:113229. [PMID: 36844432 DOI: 10.1016/j.chaos.2023.113229] [Reference Citation Analysis]
|
| 2 |
Ivanova NG. Acute Myocardial Infarction, Subclavian Vein Thrombosis, and Pulmonary Embolism Secondary to COVID-19—A Case Report. Medicina 2023;59:656. [DOI: 10.3390/medicina59040656] [Reference Citation Analysis]
|
| 3 |
Zaubitzer L, Ludwig S, Berkemann M, Walter B, Jungbauer F, Held V, Hegemann SCA, Rotter N, Schell A. The effects of COVID-19 on the vestibular system. Front Neurol 2023;14. [DOI: 10.3389/fneur.2023.1134540] [Reference Citation Analysis]
|
| 4 |
Jonmarker S, Alarcón F, Litorell J, Granholm A, Alm EJ, Chew M, Russell L, Weihe S, Madsen EK, Meier N, Leistner JW, Mårtensson J, Hollenberg J, Perner A, Kjær MN, Munch MW, Dahlberg M, Cronhjort M, Wahlin RR. Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial. Ann Intensive Care 2023;13:12. [PMID: 36862239 DOI: 10.1186/s13613-023-01115-y] [Reference Citation Analysis]
|
| 5 |
Hogwood J, Mulloy B, Lever R, Gray E, Page CP. Pharmacology of Heparin and Related Drugs: An Update. Pharmacol Rev 2023;75:328-79. [PMID: 36792365 DOI: 10.1124/pharmrev.122.000684] [Reference Citation Analysis]
|
| 6 |
Brendolin M, Fuller T, Wakimoto M, Rangel L, Rodrigues GM, Rohloff RD, Guaraldo L, Nielsen-Saines K, Brasil P. Severe maternal morbidity and mortality during the COVID-19 pandemic: a cohort study in Rio de Janeiro. IJID Reg 2023;6:1-6. [PMID: 36407853 DOI: 10.1016/j.ijregi.2022.11.004] [Reference Citation Analysis]
|
| 7 |
Quintal Martínez JP, Segura Campos MR. Flavonoids as a therapeutical option for the treatment of thrombotic complications associated with COVID-19. Phytother Res 2023;37:1092-114. [PMID: 36480428 DOI: 10.1002/ptr.7700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 2023;380:e069717. [PMID: 36849186 DOI: 10.1136/bmj-2021-069717] [Reference Citation Analysis]
|
| 9 |
Belen Apak FB, Yuce G, Topcu DI, Gultekingil A, Felek YE, Sencelikel T. Coagulopathy is Initiated with Endothelial Dysfunction and Disrupted Fibrinolysis in Patients with COVID-19 Disease. Indian J Clin Biochem 2023;:1-11. [PMID: 36816717 DOI: 10.1007/s12291-023-01118-3] [Reference Citation Analysis]
|
| 10 |
Layton R, Layton D, Beggs D, Fisher A, Mansell P, Stanger KJ. The impact of stress and anesthesia on animal models of infectious disease. Front Vet Sci 2023;10:1086003. [PMID: 36816193 DOI: 10.3389/fvets.2023.1086003] [Reference Citation Analysis]
|
| 11 |
Gris JC, Guillotin F, Dos Santos TP, Chéa M, Loubet P, Laureillard D, Sotto A, Muller L, Barbar SD, Roger C, Lefrant JY, Jung B, Klouche K, Mura T, Quéré I, Perez-Martin A. Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study. Thromb Res 2023;222:85-95. [PMID: 36608393 DOI: 10.1016/j.thromres.2022.12.019] [Reference Citation Analysis]
|
| 12 |
Han WH, Lee JH, Chun JY, Choi YJ, Kim Y, Han M, Kim JH. Predicting factors associated with prolonged intensive care unit stay of patients with COVID-19. Acute Crit Care 2023;38:41-8. [PMID: 36935533 DOI: 10.4266/acc.2022.01235] [Reference Citation Analysis]
|
| 13 |
Sanjay S, Bhakti Mistra S, Patro SK, Kawali A, Shetty R, Mahendradas P. Systemic Markers in Ophthalmic Manifestations of Post Corona Virus Disease-19 (COVID-19). Ocul Immunol Inflamm 2023;31:410-5. [PMID: 35138993 DOI: 10.1080/09273948.2021.2025253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 14 |
Mora-Delgado J, Lojo-Cruz C, Rubio Marín P, Menor Campos EM, Michán-Doña A. Enoxaparin Posology According to Prothrombotic Status and Bleeding Risk in Hospitalized Patients with SARS-CoV-2 Pneumonia. J Clin Med 2023;12. [PMID: 36769576 DOI: 10.3390/jcm12030928] [Reference Citation Analysis]
|
| 15 |
Badescu MC, Sorodoc V, Lionte C, Ouatu A, Haliga RE, Costache AD, Buliga-Finis ON, Simon I, Sorodoc L, Costache II, Rezus C. Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus. J Pers Med 2023;13. [PMID: 36675819 DOI: 10.3390/jpm13010158] [Reference Citation Analysis]
|
| 16 |
Volod O, Bunch CM, Miller J, Moore EE, Moore HB, Kwaan HC, Patel SS, Wiarda G, Aboukhaled M, Thomas SG, Fulkerson D, Erdman L, Tincher A, Walsh MM. Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on "Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11, 860". J Clin Med 2023;12. [PMID: 36675408 DOI: 10.3390/jcm12020478] [Reference Citation Analysis]
|
| 17 |
Tacquard C, Mouriaux C, Delabranche X, Bourdon C, Eckly A, Magnenat S, Sattler L, Gachet C, Mertes PM, Hechler B, Mangin PH. Platelet dysfunction and thrombus instability in flow conditions in patients with severe COVID-19. Thromb Res 2023;221:137-48. [PMID: 36376109 DOI: 10.1016/j.thromres.2022.11.004] [Reference Citation Analysis]
|
| 18 |
Jungwirth-Weinberger A, Bendich I, Hanreich C, Gonzalez Della Valle A, Blevins JL, Westrich GH, Boettner F. History of COVID-19 infection is not associated with increased D-dimer levels and risk of deep-vein thrombosis in total joint arthroplasty. Arch Orthop Trauma Surg 2023;143:785-9. [PMID: 34546422 DOI: 10.1007/s00402-021-04181-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Baycan OF, Barman HA, Bolen F, Atici A, Erman H, Korkmaz R, Calim M, Atalay B, Aciksari G, Cekmen MB, Vahaboglu H, Caliskan M. Plasminogen activator inhibitor-1 levels as an indicator of severity and mortality for COVID-19. North Clin Istanb 2023;10:1-9. [PMID: 36910430 DOI: 10.14744/nci.2022.09076] [Reference Citation Analysis]
|
| 20 |
Wolf Z. Gerinnungskomplikationen – Thromboinflammation bei Sepsis. TD 2022;20:323-326. [DOI: 10.47184/td.2022.04.09] [Reference Citation Analysis]
|
| 21 |
Kulikov AN, Teplov VM, Korshunova AА, Kovalchuk YP, Kadinskaya MI, Lapin SV, Archangelsky ND. Hemorrhagic complications in urgently hospitalized patients with severe novel coronavirus infection COVID-19. Skor med pomoŝʹ 2022;23:48-53. [DOI: 10.24884/2072-6716-2022-23-4-48-53] [Reference Citation Analysis]
|
| 22 |
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Awatif Hafiz, Mai Alalawi, Hisham A. Badreldin, Ali F. Altebainawi, Ramesh Vishwakarma, Abdulrahman Alissa, Albandari Alghamdi, Abeer A. Alenazi, Huda Al Enazi, Shahad Alanazi, Abdullah Alhammad, Jahad Alghamdi, Mashael AlFaifi, Faisal A. Al Sehli, Maram A. Aldossari, Alaa A. Alhubaishi, Anfal Y. Al-Ali, Hasan M. Al-Dorzi. Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study. Thromb J 2022;20:74. [PMID: 36482388 DOI: 10.1186/s12959-022-00432-9] [Reference Citation Analysis]
|
| 23 |
Aguilar-andino D, Umaña AN, Alas-pineda C, Santos FM, Gómez AC, Soto MM, Osorio AL. Clinical features, coagulation and inflammatory biomarkers associated with poor in-hospital outcomes in a Honduran population with RT-PCR confirmed COVID-19. Thrombosis Update 2022;9:100124. [DOI: 10.1016/j.tru.2022.100124] [Reference Citation Analysis]
|
| 24 |
Uzun G, Althaus K, Hammer S, Bakchoul T. Assessment and Monitoring of Coagulation in Patients with COVID-19: A Review of Current Literature. Hamostaseologie 2022;42:409-19. [PMID: 35477118 DOI: 10.1055/a-1755-8676] [Reference Citation Analysis]
|
| 25 |
Jing H, Wu X, Xiang M, Liu L, Novakovic VA, Shi J. Pathophysiological mechanisms of thrombosis in acute and long COVID-19. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.992384] [Reference Citation Analysis]
|
| 26 |
Hess R, Renner E, Mouland E, Sutter-Long D, Ha N. Proportion of Patients on Warfarin Therapy Who Are Eligible for Conversion to a Direct Oral Anticoagulant in the Setting of COVID-19. Ann Pharmacother 2022;:10600280221136874. [PMID: 36373362 DOI: 10.1177/10600280221136874] [Reference Citation Analysis]
|
| 27 |
Manz XD, Bogaard HJ, Aman J. Regulation of VWF (Von Willebrand Factor) in Inflammatory Thrombosis. Arterioscler Thromb Vasc Biol 2022;42:1307-20. [PMID: 36172866 DOI: 10.1161/ATVBAHA.122.318179] [Reference Citation Analysis]
|
| 28 |
Alla D, Alla SSM, Vempati R, Bhatt H, Sultana Q, Bhatt S, Mohsin T, Siddiqua A. Dengue & COVID-19: A Comparison and the Challenges at Hand. Cureus 2022;14:e31877. [PMID: 36579259 DOI: 10.7759/cureus.31877] [Reference Citation Analysis]
|
| 29 |
Saxena S, Wery AR, Khelif A, Nisolle ML, Lelubre C, Maze M, Biston P, Piagnerelli M. Plasma fibrinogen: An important piece of the COVID-19 ICU delirium puzzle? Med Hypotheses 2022;168:110953. [PMID: 36158528 DOI: 10.1016/j.mehy.2022.110953] [Reference Citation Analysis]
|
| 30 |
Kaiafa G, Savopoulos C, Karlafti E, Pantazi K, Paramythiotis D, Thomaidou E, Daios S, Ztriva E, Gionis M, Fyntanidou V, Argiriadou H, Didangelos T. Coagulation Profile of COVID-19 Patients. Life 2022;12:1658. [DOI: 10.3390/life12101658] [Reference Citation Analysis]
|
| 31 |
Wiedermann CJ. Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy. IJMS 2022;23:12474. [DOI: 10.3390/ijms232012474] [Reference Citation Analysis]
|
| 32 |
Zając P, Kaziród-wolski K, Oleś I, Sielski J, Siudak Z. Role of Fibrinolysis in the Management of Patients with COVID-19 and Thromboembolic Complications: A Review. JCDD 2022;9:356. [DOI: 10.3390/jcdd9100356] [Reference Citation Analysis]
|
| 33 |
Lupia E, Capuano M, Vizio B, Schiavello M, Bosco O, Gelardi M, Favale E, Pivetta E, Morello F, Husain S, Keshavjee S, Del Sorbo L, Montrucchio G. Thrombopoietin participates in platelet activation in COVID-19 patients. EBioMedicine 2022;85:104305. [PMID: 36242922 DOI: 10.1016/j.ebiom.2022.104305] [Reference Citation Analysis]
|
| 34 |
Januszewski M, Santor-Zaczyńska M, Ziuzia-Januszewska L, Kudan M, Jakimiuk AA, Wierzba W, Jakimiuk AJ. Postpartum Blood Loss in COVID-19 Patients-Propensity Score Matched Analysis. Biomedicines 2022;10:2517. [PMID: 36289779 DOI: 10.3390/biomedicines10102517] [Reference Citation Analysis]
|
| 35 |
Uzun G, Singh A, Abou-khalel W, Pelzl L, Weich K, Nowak-harnau S, Althaus K, Bugert P, Klüter H, Bakchoul T. Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype. Hamostaseologie 2022;42:S14-S23. [DOI: 10.1055/a-1797-0564] [Reference Citation Analysis]
|
| 36 |
Draxler DF, Brodard J, Zante B, Jakob SM, Wiegand J, Kremer Hovinga JA, Angelillo-Scherrer A, Rovo A. The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia. Thromb J 2022;20:55. [PMID: 36163073 DOI: 10.1186/s12959-022-00411-0] [Reference Citation Analysis]
|
| 37 |
Zong X, Wang X, Liu Y, Li Z, Wang W, Wei D, Chen Z. Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials. Front Med 2022;9. [DOI: 10.3389/fmed.2022.965790] [Reference Citation Analysis]
|
| 38 |
Rubens M, Saxena A, Ramamoorthy V, Ahmed MA, Zhang Z, Mcgranaghan P, Veledar E, Mcdermott M, De Los Rios La Rosa F. Hospital Outcomes among COVID-19 Hospitalizations with Acute Ischemic Stroke: Cross-Sectional Study Results from California State Inpatient Database. Brain Sciences 2022;12:1177. [DOI: 10.3390/brainsci12091177] [Reference Citation Analysis]
|
| 39 |
Zhang H, Lao Q, Zhang J, Zhu J. Coagulopathy in COVID-19 and anticoagulation clinical trials. Best Pract Res Clin Haematol 2022;35:101377. [PMID: 36494146 DOI: 10.1016/j.beha.2022.101377] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Kell DB, Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J 2022;479:1653-708. [PMID: 36043493 DOI: 10.1042/BCJ20220154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Tudoran C, Velimirovici DE, Berceanu-vaduva DM, Rada M, Voiţă-mekeres F, Tudoran M. Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19. Microorganisms 2022;10:1738. [DOI: 10.3390/microorganisms10091738] [Reference Citation Analysis]
|
| 42 |
Lin R, Hu X, Chen S, Huang J. Sports Participation and Anti-Epidemic: Empirical Evidence on the Influence of Regular Physical Activity on the COVID-19 Pandemic in Mainland China. Int J Environ Res Public Health 2022;19. [PMID: 36078405 DOI: 10.3390/ijerph191710689] [Reference Citation Analysis]
|
| 43 |
Cabrera-Garcia D, Miltiades A, Yim P, Parsons S, Elisman K, Mansouri MT, Wagener G, Harrison NL. Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients. Int J Hematol 2022. [PMID: 35994163 DOI: 10.1007/s12185-022-03437-2] [Reference Citation Analysis]
|
| 44 |
Urwyler P, Moser S, Trendelenburg M, Sendi P, Osthoff M. Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. Mol Immunol 2022;150:99-113. [PMID: 36030710 DOI: 10.1016/j.molimm.2022.08.008] [Reference Citation Analysis]
|
| 45 |
Xu X, Feng Y, Jia Y, Zhang X, Li L, Bai X, Jiao L. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis. Thromb Res 2022;218:83-98. [PMID: 36027630 DOI: 10.1016/j.thromres.2022.08.017] [Reference Citation Analysis]
|
| 46 |
Singh A, Brandow AM, Wun T, Shet AS. COVID-19 and venous thromboembolism risk in patients with sickle cell disease. Blood Advances 2022;6:4408-4412. [DOI: 10.1182/bloodadvances.2022007219] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 47 |
Singh A, Brandow AM, Wun T, Shet AS. COVID-19 and venous thromboembolism risk in patients with sickle cell disease. Blood Adv 2022;6:4408-12. [PMID: 35763429 DOI: 10.1182/bloodadvances.2022007219] [Reference Citation Analysis]
|
| 48 |
Romaní L, León-figueroa DA, Rafael-navarro D, Barboza JJ, Rodriguez-morales AJ. Association between the Use of Antibiotics and the Development of Acute Renal Injury in Patients Hospitalized for COVID-19 in a Hospital in the Peruvian Amazon. JCM 2022;11:4493. [DOI: 10.3390/jcm11154493] [Reference Citation Analysis]
|
| 49 |
Chi G, Lee JJ, Memar Montazerin S, Marszalek J. Association of D-dimer with short-term risk of venous thromboembolism in acutely ill medical patients: A systematic review and meta-analysis. Vasc Med 2022;:1358863X221109855. [PMID: 35913041 DOI: 10.1177/1358863X221109855] [Reference Citation Analysis]
|
| 50 |
Carpenter RM, Young MK, Petri WAO, Lyons GR, Gilchrist C, Carey RM, Petri WA Jr. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation. mSphere 2022;:e0022022. [PMID: 35913134 DOI: 10.1128/msphere.00220-22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 51 |
Williams JO, Nash J, Whelan C, Raven BM, Davies AJ, Evans J, Watkeys L, Morris K, James PE. Early but reversible haemostatic changes in a-symptomatic females expressing COVID-19 antibodies. Thromb Res 2022;217:76-85. [PMID: 35908384 DOI: 10.1016/j.thromres.2022.07.012] [Reference Citation Analysis]
|
| 52 |
Holzmer SW, Walsh CA, Mohiuddin W, Sharpe FE. Limb Fasciotomy for COVID-19 Patients: Is the Chance to Cut a Chance to Cure? Plastic and Reconstructive Surgery - Global Open 2022;10:e4454. [DOI: 10.1097/gox.0000000000004454] [Reference Citation Analysis]
|
| 53 |
Mamzer A, Waligora M, Kopec G, Ptaszynska-Kopczynska K, Kurzyna M, Darocha S, Florczyk M, Mroczek E, Mularek-Kubzdela T, Smukowska-Gorynia A, Wrotynski M, Chrzanowski L, Dzikowska-Diduch O, Perzanowska-Brzeszkiewicz K, Pruszczyk P, Skoczylas I, Lewicka E, Blaszczak P, Karasek D, Kusmierczyk-Droszcz B, Mizia-Stec K, Kaminski K, Jachec W, Peregud-Pogorzelska M, Doboszynska A, Gasior Z, Tomaszewski M, Pawlak A, Zablocka W, Ryczek R, Widejko-Pietkiewicz K, Kasprzak JD. Impact of the COVID-19 Pandemic on Pulmonary Hypertension Patients: Insights from the BNP-PL National Database. Int J Environ Res Public Health 2022;19:8423. [PMID: 35886278 DOI: 10.3390/ijerph19148423] [Reference Citation Analysis]
|
| 54 |
Sochet AA, Morrison JM, Jaffray J, Godiwala N, Wilson HP, Thornburg CD, Bhat RV, Zia A, Lawrence C, Kudchadkar SR, Hamblin F, Russell CJ, Streiff MB, Spyropoulos AC, Amankwah EK, Goldenberg NA; COVID-19 Anticoagulation in Children – Thromboprophylaxis (COVAC-TP) Trial Investigators. Enoxaparin Thromboprophylaxis in Children Hospitalized for COVID-19: A Phase 2 Trial. Pediatrics 2022;150:e2022056726. [PMID: 35484817 DOI: 10.1542/peds.2022-056726] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 55 |
Schmitz AH, Wood KE, Burghardt EL, Koestner BP, Wendt LH, Badheka AV, Sharathkumar AA. Thromboprophylaxis for children hospitalized with COVID-19 and MIS-C. Res Pract Thromb Haemost 2022;6:e12780. [PMID: 35949885 DOI: 10.1002/rth2.12780] [Reference Citation Analysis]
|
| 56 |
Karataş Kiliçcioğlu G, Kaya T, İşsever K, Güçlü E, Karabay O. COVID-19 hastalarında koagülopati için C-reaktif protein/albumin oranının tanısal doğruluğu. Cukurova Med J 2022;47:622-628. [DOI: 10.17826/cumj.1050419] [Reference Citation Analysis]
|
| 57 |
Singh A, Brandow AM, Wun T, Shet AS. COVID-19 and Venous Thromboembolism Risk in Patients With Sickle Cell Disease. Blood Adv 2022:bloodadvances. [PMID: 35763429 DOI: 10.1182/bloodadvances.2022007219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 58 |
Schneider M. The Role of Biomarkers in Hospitalized COVID-19 Patients With Systemic Manifestations. Biomark�Insights 2022;17:117727192211089. [DOI: 10.1177/11772719221108909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 59 |
Tamayo-Velasco Á, Bombín-Canal C, Cebeira MJ, Sánchez-De Prada L, Miramontes-González JP, Martín-Fernández M, Peñarrubia-Ponce MJ. Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic. J Clin Med 2022;11. [PMID: 35743512 DOI: 10.3390/jcm11123443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 60 |
Săbiescu DM, Kamal AM, Kamal CK, Alexandru DO, Mitruț P. Liver damage in the context of SARS-CoV-2. Covid-19 treatment and its effects on the liver. J Med Life 2022;15:727-34. [PMID: 35928369 DOI: 10.25122/jml-2022-0177] [Reference Citation Analysis]
|
| 61 |
Ostrovskyi M, Konopkina L, Gashynova K, Gumeniuk G, Dobrianskyi D, Bororova O. Pathogenetic treatment of patients with COVID-19 at the outpatient stage. IC 2022. [DOI: 10.32902/2663-0338-2022-1-23-31] [Reference Citation Analysis]
|
| 62 |
Mohan G, Wilson W, Paonam B, Vaidya A, Ravindra P, Shastry S, Balakrishnan JM, Rao S, Chaudhuri S. Utility of Thromboelastography and velocity curve derivative in diagnosing COVID-19 associated coagulopathy. Int J Lab Hematol 2022. [PMID: 35609623 DOI: 10.1111/ijlh.13876] [Reference Citation Analysis]
|
| 63 |
Balachander A, Lee B, Biswas SK, Lye DC, Lin RT, Leo YS, Chui P, Ng LF, Renia L. Organ-specific immune response in lethal SARS-CoV-2 infection by deep spatial phenotyping. Clin Transl Immunology 2022;11:e1384. [PMID: 35602886 DOI: 10.1002/cti2.1384] [Reference Citation Analysis]
|
| 64 |
Olgers TJ, Lieveld AWE, Kok B, Heijmans J, Salet D, Assman NL, Postma DF, Bauer MP, Nanayakkara PWB, Meijer K, Bosch FH, Kooistra H. Screening for asymptomatic deep vein thrombosis in COVID-19 patients admitted to the medical ward: a cross-sectional study. J Ultrasound 2022. [PMID: 35567703 DOI: 10.1007/s40477-022-00689-w] [Reference Citation Analysis]
|
| 65 |
Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 66 |
Abd El-lateef AE, Alghamdi S, Ebid G, Khalil K, Kabrah S, Abdel Ghafar MT. Coagulation Profile in COVID-19 Patients and its Relation to Disease Severity and Overall Survival: A Single-Center Study. Br J Biomed Sci 2022;79:10098. [DOI: 10.3389/bjbs.2022.10098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Bull BS, Hay KL, Herrmann PC. Fibrin Strands Will Grow from Soluble Fibrin and Hang Up in an In Vitro Microcirculatory Viscoelastic Model: Is This a Major Cause of COVID-19 Associated Coagulopathy? JCM 2022;11:2084. [DOI: 10.3390/jcm11082084] [Reference Citation Analysis]
|
| 68 |
Shepherd TD, Niaz TS, Yadav R. Massive pulmonary embolism treated with low-dose thrombolysis on the geriatric ward during the COVID-19 pandemic. BMJ Case Rep 2022;15:e248125. [PMID: 35387790 DOI: 10.1136/bcr-2021-248125] [Reference Citation Analysis]
|
| 69 |
Reddy DH, Atam V, Rai P, Khan F, Pandey S, Malhotra HS, Gupta KK, Sonkar SK, Verma R, Usman K, Chaudhary SC, Sonkar SK, Kumar V, Sawlani KK, Gupta KK, Patel M, Himanshu D, Kumar A, Verma SK, Gautam M, Gupta H, Kumar S, Baghchandanani D, Yadav A, Lamba M, Kumar A, Suhail, Prabha R, Bajaj D, Singh AB, Mahendra M, Kumar G, Kumar N, Ojha BK, Verma R, Verma DK, Kumar V, Singh S, Gupta S, Hashim M, Verma K, Bhardwaj A, Chaudhary A, Chaudhan H, Kaustubh, Dubey K, Kumar N, Rituraj, Kumar J, Srivastav S, Singh SP, Kumari S, Srivastave S, Verma J, Hussain MA, Siddiqui AS, Rizvi A, Pancholi C, Sharma D, Verma DK, Zothansanga D, Singh K, Singh PK, Kumar R, Bharti VR, Ansari SA, Kumar V, Kallani M, Bharti H, Singh A, Majumdar A, Verma N, Mishra M, Gupta PK, Shivhare S, Kotwal M, Mahar P, Mall P, Parmar KS, Kumar G. COVID-19 cases and their outcome among patients with uncommon co-existing illnesses: A lesson from Northern India. Clinical Epidemiology and Global Health 2022. [DOI: 10.1016/j.cegh.2022.101044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Kantarcioglu B, Darki A, Siddiqui F, Hoppensteadt D, Lewis J, Krämer R, Adiguzel C, Fareed J. The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients. Clin Appl Thromb Hemost 2022;28:107602962210917. [DOI: 10.1177/10760296221091770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 71 |
Yamada S, Asakura H. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. IJMS 2022;23:3338. [DOI: 10.3390/ijms23063338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 72 |
Almskog LM, Wikman A, Svensson J, Bottai M, Kotormán M, Wahlgren CM, Wanecek M, van der Linden J, Ågren A. Hypercoagulation Detected by Rotational Thromboelastometry Predicts Mortality in COVID-19: A Risk Model Based on a Prospective Observational Study. TH Open 2022;6:e50-9. [PMID: 35265789 DOI: 10.1055/a-1725-9221] [Reference Citation Analysis]
|
| 73 |
Karikalan S, Sharma M, Chandna M, Sachdev M, Gaalla A, Yasmin F, Shah R, Ratnani I, Surani S. Intracardiac Thrombus in Coronavirus Disease-2019. Cureus. [DOI: 10.7759/cureus.22883] [Reference Citation Analysis]
|
| 74 |
Mouliou DS, Pantazopoulos I, Gourgoulianis KI. COVID-19 smart diagnosis in the Emergency Department: all-in in practice. Expert Rev Respir Med 2022. [PMID: 35245149 DOI: 10.1080/17476348.2022.2049760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 75 |
Konstantinides S, Mavromanoli A, Hobohm L. COVID-19 und Thrombosen. Kardiologie up2date 2022;18:65-86. [DOI: 10.1055/a-1402-5103] [Reference Citation Analysis]
|
| 76 |
Iba T, Levy JH. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. Trends Cardiovasc Med 2022:S1050-1738(22)00038-X. [PMID: 35202800 DOI: 10.1016/j.tcm.2022.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 77 |
Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J 2022;479:537-59. [PMID: 35195253 DOI: 10.1042/BCJ20220016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 78 |
Savastano MC, Larici AR, Crincoli E, De Filippis A, Cicchetti G, Gambini G, Savastano A, Marano R, Natale L, Rizzo S. Retinal vascular impairment matched to the pulmonary damage in early post-COVID 19 patients. Eur J Ophthalmol 2022;:11206721221079153. [PMID: 35174719 DOI: 10.1177/11206721221079153] [Reference Citation Analysis]
|
| 79 |
Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin Appl Thromb Hemost 2022;28:10760296211056648. [PMID: 35167393 DOI: 10.1177/10760296211056648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 80 |
Maramattom BV. Multiple Ischemic Strokes Due to Multisystem Inflammatory Syndrome in Adults (MIS-A). Cureus 2022. [DOI: 10.7759/cureus.22103] [Reference Citation Analysis]
|
| 81 |
Campello E, Radu CM, Simion C, Spiezia L, Bulato C, Gavasso S, Tormene D, Perin N, Turatti G, Simioni P. Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19. Front Cell Dev Biol 2021;9:770463. [PMID: 35111751 DOI: 10.3389/fcell.2021.770463] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 82 |
Chen AT, Wang CY, Zhu WL, Chen W. Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review. Aging Dis 2022;13:144-56. [PMID: 35111367 DOI: 10.14336/AD.2021.0704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 83 |
Shimohata T. Neuro-COVID-19. Clin Exp Neuroimmunol. 2021;. [PMID: 34899999 DOI: 10.1111/cen3.12676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 84 |
Vincent JL, Levi M, Hunt BJ. Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia. Lancet Respir Med 2022;10:214-20. [PMID: 34838161 DOI: 10.1016/S2213-2600(21)00455-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 85 |
Schrottmaier WC, Pirabe A, Pereyra D, Heber S, Hackl H, Schmuckenschlager A, Brunnthaler L, Santol J, Kammerer K, Oosterlee J, Pawelka E, Treiber SM, Khan AO, Pugh M, Traugott MT, Schörgenhofer C, Seitz T, Karolyi M, Jilma B, Rayes J, Zoufaly A, Assinger A. Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications. Front Cardiovasc Med 2022;8:802566. [DOI: 10.3389/fcvm.2021.802566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 86 |
Marvi TK, Stubblefield WB, Tillman BF, Tenforde MW, Patel MM, Lindsell CJ, Self WH, Grijalva CG, Rice TW. Serial Thromboelastography and the Development of Venous Thromboembolism in Critically Ill Patients With COVID-19. Crit Care Explor 2022;4:e0618. [PMID: 35072082 DOI: 10.1097/CCE.0000000000000618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 87 |
Ayyildiz A, Çobaner N, Yelken B. Sepsis induced coagulopathy score and D-dimer levels in COVID-19 patients followed in intensive care; what has changed in COVID era? Journal of Health Sciences and Medicine 2022;5:94-8. [DOI: 10.32322/jhsm.992132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 88 |
Dugbartey GJ, Alornyo KK, Ohene BO, Boima V, Antwi S, Sener A. Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy. Nitric Oxide 2022;120:16-25. [PMID: 35032641 DOI: 10.1016/j.niox.2022.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 89 |
Aquino L, Muniz JC, Laufer PM, Prieto LR. Gore Cardioform ASD device thrombus weeks after COVID-19 infection. Catheter Cardiovasc Interv 2022. [PMID: 35018709 DOI: 10.1002/ccd.30067] [Reference Citation Analysis]
|
| 90 |
Wieteska-miłek M, Kurzyna M. Thromboembolic Events in COVID-19. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_12] [Reference Citation Analysis]
|
| 91 |
Tagami T, Yamakawa K, Endo A, Hayakawa M, Ogura T, Hirayama A, Yasunaga H. Japanese Multicenter Research of COVID-19 by Assembling Real-world Data: A Study Protocol. Ann Clin Epidemiol 2022;4:92-100. [DOI: 10.37737/ace.22012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 92 |
Richardson GM, Su SW, Iragorri S. Case report: Diarrhea-associated hemolytic uremic syndrome in the Era of COVID-19. Front Pediatr 2022;10:979850. [PMID: 36389381 DOI: 10.3389/fped.2022.979850] [Reference Citation Analysis]
|
| 93 |
Ascari A, Meani P, Cotza M. ECMO in COVID-19: Bleeding and Thrombosis. The Coagulation Labyrinth of Covid-19 2022. [DOI: 10.1007/978-3-030-82938-4_12] [Reference Citation Analysis]
|
| 94 |
Panigada M, Meli A, Dalton HJ. Coagulation Disorders and Management. COVID-19 Critical and Intensive Care Medicine Essentials 2022. [DOI: 10.1007/978-3-030-94992-1_20] [Reference Citation Analysis]
|
| 95 |
Shoeb F, Mahdi F, Hussain I. Gender Differences Associated with Hyper-Inflammatory Conditions in COVID-19 Patients. Aging and disease 2022. [DOI: 10.14336/ad.2022.0830] [Reference Citation Analysis]
|
| 96 |
Aimrane A, El-mansoury B, Sabir S, El Baz S, Zouhairi N, Echchakery M, Draoui A, Hicham C, Fdil N, Sellami S, Ferssiwi A, Bitar A, Rais H. SARS-Cov-2 and Associated Heart Failure. Handbook of Research on Pathophysiology and Strategies for the Management of COVID-19 2022. [DOI: 10.4018/978-1-7998-8225-1.ch010] [Reference Citation Analysis]
|
| 97 |
Sabouret P, Sulman D, Buffet G, Testa A, Biondi-zoccai G. Pulmonary Embolism After COVID-19 (Epidemiology, Influence on Prognosis, Pathogenesis, Treatment). Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_14] [Reference Citation Analysis]
|
| 98 |
Chikere CB, Tekere M, Opeolu BO, Arts G, Ofori LA, Odu NN. Research Collaborations for Enhanced Performance and Visibility of Women Scientists. Science by Women 2022. [DOI: 10.1007/978-3-030-83032-8_4] [Reference Citation Analysis]
|
| 99 |
Robinson K, Schott LL, Matthews T, Tyagi M, Ajmani VB, Sacco N, Cao Z. Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19. Clin Appl Thromb Hemost 2022;28:107602962211378. [DOI: 10.1177/10760296221137848] [Reference Citation Analysis]
|
| 100 |
Shirani K, Ashraf M, Sherafat A, Naderi Z, Sami R, Soltaninejad F, Khodadadi S, Mashayekhbakhsh S, Sharafi N, Ahmadi S, Shayganfar A, Zand I, Ajami A. Association of systemic complications with mortality in coronavirus disease of 2019: A cohort study on intensive care unit patients. J Res Med Sci 2022;27:34. [DOI: 10.4103/jrms.jrms_1213_20] [Reference Citation Analysis]
|
| 101 |
Miltiades A, Houck PJ, Monteleone M, Harrison NL, Cabrera-Garcia D, Roh D, Wagener G. Insights into Fibrinogen-Mediated COVID-19 Hypercoagubility in Critically Ill Patients. J Neurosurg Anesthesiol 2022;34:136-40. [PMID: 34870637 DOI: 10.1097/ANA.0000000000000812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 102 |
Brenner B, Ay C, Le Gal G, Carrier M, Muñoz AJ, Agnelli G, Cavalcanti Rocha AT, Abdel-razeq H, Elalamy I, Falanga A. Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need. Thrombosis Update 2022. [DOI: 10.1016/j.tru.2022.100098] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 103 |
Shi R, Monnet X, Teboul J. Fluid Management in COVID-19 ICU Patients. Annual Update in Intensive Care and Emergency Medicine 2022. [DOI: 10.1007/978-3-030-93433-0_14] [Reference Citation Analysis]
|
| 104 |
Balchandra A, Ghatak T, Samanta S, Singh R, Verma A, Mishra P, Chaudhary R, Nath A. Pattern of conventional coagulation and thromboelastographic parameters in patients with COVID-19 diseases and association of COVID-associated coagulopathy with mortality in intensive care unit. Anesth Essays Res 2022;0:0. [DOI: 10.4103/aer.aer_52_22] [Reference Citation Analysis]
|
| 105 |
Woo S, Kim B, Heo NH, Kim MS, Yoon YA, Choi YJ. Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection. Clin Appl Thromb Hemost 2022;28:10760296221127276. [PMID: 36172745 DOI: 10.1177/10760296221127276] [Reference Citation Analysis]
|
| 106 |
Marochkov AV, Lipnitski AL, Starovoitov AG, Dazortsava VU, Livinskaya VA. Integrative parameter of platelet aggregation in intensive care of COVID-19 patients. jour 2021;18:99-107. [DOI: 10.51523/2708-6011.2021-18-4-13] [Reference Citation Analysis]
|
| 107 |
Schrottmaier WC, Pirabe A, Pereyra D, Heber S, Hackl H, Schmuckenschlager A, Brunnthaler L, Santol J, Kammerer K, Oosterlee J, Pawelka E, Treiber SM, Khan AO, Pugh M, Traugott MT, Schörgenhofer C, Seitz T, Karolyi M, Jilma B, Rayes J, Zoufaly A, Assinger A. Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype. Front Cardiovasc Med 2021;8:795624. [PMID: 34957266 DOI: 10.3389/fcvm.2021.795624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 108 |
Patel A, Ajayi F, Ali R, Chan KH, Slim J. Dilemma of Anticoagulation Therapy in Mild or Asymptomatic COVID-19 Cases. Cureus 2021;13:e19291. [PMID: 34900472 DOI: 10.7759/cureus.19291] [Reference Citation Analysis]
|
| 109 |
Mellema RA, Crandell J, Petrey AC. Platelet Dysregulation in the Pathobiology of COVID-19. Hamostaseologie 2021. [PMID: 34879421 DOI: 10.1055/a-1646-3392] [Reference Citation Analysis]
|
| 110 |
Otsubo S, Wakabayashi S, Aoyama Y, Kinoshita K, Minami M, Ohsima Y, Kobayashi S, Otsubo Y. Characteristics of hemodialysis patient with critical COVID-19. Ther Apher Dial 2021. [PMID: 34870889 DOI: 10.1111/1744-9987.13773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 111 |
Smirnov AV, Ermilov VV, Dorofeev NA, Tolokolnikov VA, Chernetsky OA, Poplavsky AE, Botasheva VS, Samusev RP, Alexandrova LI, Belik TA, Makarova MM, Gurov DY. [Features of pathological anatomy of COVID-19 according to autopsy results in the Volgograd Region]. Arkh Patol 2021;83:5-13. [PMID: 34859980 DOI: 10.17116/patol2021830615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 112 |
Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PLoS Pathog 2021;17:e1010118. [PMID: 34860860 DOI: 10.1371/journal.ppat.1010118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 113 |
Lim MS, Mcrae S. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications. Crit Rev Oncol Hematol 2021;168:103529. [PMID: 34800652 DOI: 10.1016/j.critrevonc.2021.103529] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 114 |
Kim TE, Lebedev DA, Magomedbekov MM, Nugumanova KA, Petrikov SS, Popugayev KA, Rogal ML, Yartsev PA. A Multidisciplinary Approach to the Treatment of COVID-Associated Complications After Pancreatoduodenal Resection (Case Report). Neotložnaâ med pomoŝʹ 2021;10:469-476. [DOI: 10.23934/2223-9022-2021-10-3-469-476] [Reference Citation Analysis]
|
| 115 |
Subramanyam K, Johny D, Bhat S, Raghothama S. De novo right ventricular thrombus in a COVID-19-positive patient. BMJ Case Rep 2021;14:e247380. [PMID: 34794982 DOI: 10.1136/bcr-2021-247380] [Reference Citation Analysis]
|
| 116 |
Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 117 |
Tilinca MC, Gliga MC, Varga A. The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review. The Journal of Critical Care Medicine 2021;0. [DOI: 10.2478/jccm-2021-0024] [Reference Citation Analysis]
|
| 118 |
Cabrera-garcia D, Miltiades A, Yim P, Parsons S, Elisman K, Mansouri MT, Wagener G, Harrison NL. Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients.. [DOI: 10.1101/2021.11.10.21266185] [Reference Citation Analysis]
|
| 119 |
Bernstein CN, Singh H, Murthy SK, Nguyen GC, Benchimol EI, Bitton A, Kuenzig ME, Huang JG, Jones JL, Lee K, Targownik LE, Windsor JW, Mukhtar MS, Tandon P, Kaplan GG. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD. J Can Assoc Gastroenterol 2021;4:S34-9. [PMID: 34755037 DOI: 10.1093/jcag/gwab025] [Reference Citation Analysis]
|
| 120 |
Othman M, Baker AT, Gupalo E, Elsebaie A, Bliss CM, Rondina MT, Lillicrap D, Parker AL. To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia. J Thromb Haemost 2021;19:2845-56. [PMID: 34351057 DOI: 10.1111/jth.15485] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 121 |
Zhao X, Tao M, Chen C, Zhang Y, Fu Y. Clinical Features and Factors Associated with Occult Gastrointestinal Bleeding in COVID-19 Patients. Infect Drug Resist 2021;14:4217-26. [PMID: 34703248 DOI: 10.2147/IDR.S335868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 122 |
Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Righini M, Sanfilippo KM, Siegal D, Skara M, Terrell DR, Touri K, Akl EA, Bou Akl I, Bognanni A, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Muti-Schünemann G, Noori A, Philip BA, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Wiercioch W, Mustafa RA, Schünemann HJ. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv 2021;5:3951-9. [PMID: 34474482 DOI: 10.1182/bloodadvances.2021005493] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 123 |
Leslie-Mazwi TM, Srivatanakul K. Coronavirus disease 2019 and stroke. Interv Neuroradiol 2021;27:13-8. [PMID: 34670419 DOI: 10.1177/15910199211035920] [Reference Citation Analysis]
|
| 124 |
Cremer S, Pilgram L, Berkowitsch A, Stecher M, Rieg S, Shumliakivska M, Bojkova D, Wagner JUG, Aslan GS, Spinner C, Luxán G, Hanses F, Dolff S, Piepel C, Ruppert C, Guenther A, Rüthrich MM, Vehreschild JJ, Wille K, Haselberger M, Heuzeroth H, Hansen A, Eschenhagen T, Cinatl J, Ciesek S, Dimmeler S, Borgmann S, Zeiher A; LEOSS study group. Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. PLoS One 2021;16:e0258684. [PMID: 34673795 DOI: 10.1371/journal.pone.0258684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 125 |
Ostaszewski M, Niarakis A, Mazein A, Kuperstein I, Phair R, Orta-Resendiz A, Singh V, Aghamiri SS, Acencio ML, Glaab E, Ruepp A, Fobo G, Montrone C, Brauner B, Frishman G, Monraz Gómez LC, Somers J, Hoch M, Kumar Gupta S, Scheel J, Borlinghaus H, Czauderna T, Schreiber F, Montagud A, Ponce de Leon M, Funahashi A, Hiki Y, Hiroi N, Yamada TG, Dräger A, Renz A, Naveez M, Bocskei Z, Messina F, Börnigen D, Fergusson L, Conti M, Rameil M, Nakonecnij V, Vanhoefer J, Schmiester L, Wang M, Ackerman EE, Shoemaker JE, Zucker J, Oxford K, Teuton J, Kocakaya E, Summak GY, Hanspers K, Kutmon M, Coort S, Eijssen L, Ehrhart F, Rex DAB, Slenter D, Martens M, Pham N, Haw R, Jassal B, Matthews L, Orlic-Milacic M, Senff Ribeiro A, Rothfels K, Shamovsky V, Stephan R, Sevilla C, Varusai T, Ravel JM, Fraser R, Ortseifen V, Marchesi S, Gawron P, Smula E, Heirendt L, Satagopam V, Wu G, Riutta A, Golebiewski M, Owen S, Goble C, Hu X, Overall RW, Maier D, Bauch A, Gyori BM, Bachman JA, Vega C, Grouès V, Vazquez M, Porras P, Licata L, Iannuccelli M, Sacco F, Nesterova A, Yuryev A, de Waard A, Turei D, Luna A, Babur O, Soliman S, Valdeolivas A, Esteban-Medina M, Peña-Chilet M, Rian K, Helikar T, Puniya BL, Modos D, Treveil A, Olbei M, De Meulder B, Ballereau S, Dugourd A, Naldi A, Noël V, Calzone L, Sander C, Demir E, Korcsmaros T, Freeman TC, Augé F, Beckmann JS, Hasenauer J, Wolkenhauer O, Wilighagen EL, Pico AR, Evelo CT, Gillespie ME, Stein LD, Hermjakob H, D'Eustachio P, Saez-Rodriguez J, Dopazo J, Valencia A, Kitano H, Barillot E, Auffray C, Balling R, Schneider R; COVID-19 Disease Map Community. COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms. Mol Syst Biol 2021;17:e10387. [PMID: 34664389 DOI: 10.15252/msb.202110387] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 126 |
Wouters V, Gadisseur A, Kenyon C. Tromboseprofylaxe na doorgemaakte Covid-19: een onopgelost raadsel. Tijdschr Geneesk 2021. [DOI: 10.47671/tvg.77.21.162] [Reference Citation Analysis]
|
| 127 |
Nagori EK, Smith R, Sorto F, Hasan M. Development of Arterial Thrombosis in a Patient on Therapeutic Anticoagulation for COVID-19. Cureus 2021;13:e17644. [PMID: 34646692 DOI: 10.7759/cureus.17644] [Reference Citation Analysis]
|
| 128 |
Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol 2021;21:370. [PMID: 34635073 DOI: 10.1186/s12876-021-01939-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 129 |
Seregina EA, Koltsova EM, Ataullakhanov FI, Rumyantsev AG. Laboratory parameters of hemostasis in patients with COVID-19. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2021;20:147-155. [DOI: 10.24287/1726-1708-2021-20-3-147-155] [Reference Citation Analysis]
|
| 130 |
Nekaeva ES, Bolshakova AE, Malysheva ES, Galova EA, Makarova EV, Nekrasova TA, Polyakova IV, Bedretdinova ZS, Belikina DV, Lavrenyuk AA, Fomin IV. Gender Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults. Sovrem Tekhnologii Med 2021;13:16-24. [PMID: 34603760 DOI: 10.17691/stm2021.13.4.02] [Reference Citation Analysis]
|
| 131 |
Odom CV, Kim Y, Burgess CL, Baird LA, Korkmaz FT, Na E, Shenoy AT, Arafa EI, Lam TT, Jones MR, Mizgerd JP, Traber KE, Quinton LJ. Liver-Dependent Lung Remodeling during Systemic Inflammation Shapes Responses to Secondary Infection. J Immunol 2021;207:1891-902. [PMID: 34470857 DOI: 10.4049/jimmunol.2100254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 132 |
Greenway A, Leahy N, Torrieri L, An A, Fink SA, Witenko C, Shikar M, Winchell RJ, Barie PS, Liu SI. Skin Failure Among Critically Ill Patients Afflicted with Coronavirus Disease 2019 (COVID-19). J Intensive Care Med 2021;36:1331-9. [PMID: 34591701 DOI: 10.1177/08850666211046532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 133 |
Villar M, Urra JM, Rodríguez-Del-Río FJ, Artigas-Jerónimo S, Jiménez-Collados N, Ferreras-Colino E, Contreras M, de Mera IGF, Estrada-Peña A, Gortázar C, de la Fuente J. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology. Front Immunol 2021;12:730710. [PMID: 34566994 DOI: 10.3389/fimmu.2021.730710] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 134 |
Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 135 |
Zabolotnaya SV, Bogolepova AN, Tairova RT. [COVID-19-associated stroke]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:5-10. [PMID: 34553575 DOI: 10.17116/jnevro20211210825] [Reference Citation Analysis]
|
| 136 |
Ray JG, Warkentin TE, Park AL. Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group. Thromb Res 2021;207:62-5. [PMID: 34555698 DOI: 10.1016/j.thromres.2021.09.008] [Reference Citation Analysis]
|
| 137 |
Tsyganova EV, Glukhoedova NV, Zhilenkova AS, Fedoseeva TI, Iushchuk EN, Smetneva NS. COVID-19 and features of cardiovascular involvement. Terapevticheskii arkhiv 2021;93:1091-9. [DOI: 10.26442/00403660.2021.09.201036] [Reference Citation Analysis]
|
| 138 |
Mezgebe M, Jacobson BF, Mayne ES, Louw S. Change in platelet indices in patients with Coronavirus disease-2019 (COVID-19): A reflection of platelet activation and contribution to immunothrombosis? Int J Lab Hematol 2021. [PMID: 34519428 DOI: 10.1111/ijlh.13705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 139 |
Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. An Interactive Single Cell Web Portal Identifies Gene and Cell Networks in COVID-19 Host Responses. iScience 2021;:103115. [PMID: 34522848 DOI: 10.1016/j.isci.2021.103115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 140 |
Orso D, Mattuzzi L, Scapol S, Delrio S, Vetrugno L, Bove T. Phlegmasia cerulea dolens superimposed on disseminated intravascular coagulation in COVID-19. Acta Biomed 2021;92:e2021101. [PMID: 34487073 DOI: 10.23750/abm.v92i4.11478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 141 |
Wernlein SM. Placental Thrombus After Maternal COVID-19 Infection: A Case Study. Journal of Diagnostic Medical Sonography 2021;37:507-509. [DOI: 10.1177/87564793211024235] [Reference Citation Analysis]
|
| 142 |
Kobelev E, Bergen TA, Tarkova AR, Vasiltseva OY, Kamenskaya OV, Usov VY, Chernyavsky AM. COVID-19 as a cause of chronic pulmonary hypertension: pathophysiological rationale and potential of instrumental investigations. Cardiovasc Ther Prev 2021;20:2844. [DOI: 10.15829/1728-8800-2021-2844] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 143 |
Ladozhskaya-gapeenko EE, Khrapov KN, Polushin YS, Shlyk IV, Petrishchev NN, Vartanova IV. Microcirculation Disorders in Patients with Severe COVID-19. Vestn anesteziol reanimatol 2021;18:7-19. [DOI: 10.21292/2078-5658-2021-18-4-7-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 144 |
Zifkos K, Dubois C, Schäfer K. Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence. Int J Mol Sci 2021;22:9317. [PMID: 34502228 DOI: 10.3390/ijms22179317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 145 |
Blot M, de Maistre E, Bourredjem A, Quenot JP, Nguyen M, Bouhemad B, Charles PE, Binquet C, Piroth L. Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia. Front Med (Lausanne) 2021;8:675191. [PMID: 34422854 DOI: 10.3389/fmed.2021.675191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 146 |
Xu Z, Xu Y, Liu D, Liu X, Zhou L, Huang Y, Li Y, Liu X. Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19. Front Med (Lausanne) 2021;8:681548. [PMID: 34422856 DOI: 10.3389/fmed.2021.681548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 147 |
Kleineberg NN, Knauss S, Gülke E, Pinnschmidt HO, Jakob CEM, Lingor P, Hellwig K, Berthele A, Höglinger G, Fink GR, Endres M, Gerloff C, Klein C, Stecher M, Classen AY, Rieg S, Borgmann S, Hanses F, Rüthrich MM, Hower M, Tometten L, Haselberger M, Piepel C, Merle U, Dolff S, Degenhardt C, Jensen BO, Vehreschild MJGT, Erber J, Franke C, Warnke C; LEOSS Study Group. Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS). Eur J Neurol 2021. [PMID: 34411383 DOI: 10.1111/ene.15072] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 148 |
Valle EO, Cabrera CPS, Albuquerque CCC, Silva GVD, Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Lins PRG, Rodrigues CE. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study. Crit Care 2021;25:299. [PMID: 34412667 DOI: 10.1186/s13054-021-03729-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 149 |
Raychaudhuri S, Pujani M, Menia R, Verma N, Singh M, Chauhan V, Jain M, Chandoke RK, Kaur H, Agrawal S, Singh A. COVID-19 Associated Coagulopathy in an Indian Scenario: A Correlation with Disease Severity and Survival Status. Indian J Hematol Blood Transfus 2021;:1-11. [PMID: 34426721 DOI: 10.1007/s12288-021-01465-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 150 |
Shahidi-Dadras M, Shahrigharahkoshan S, Yazdi E, Fatemi A, Mahboubi-Fooladi Z, Dadkhahfar S. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic. Adv Emerg Nurs J 2021;43:194-7. [PMID: 34397495 DOI: 10.1097/TME.0000000000000361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 151 |
Advani R, Strømsnes TA, Stjernstrøm E, Lugg ST. Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19. Thromb J 2021;19:57. [PMID: 34407847 DOI: 10.1186/s12959-021-00304-8] [Reference Citation Analysis]
|
| 152 |
Meazza Prina M, Martini F, Bracchi F, Di Mauro D, Fargnoli A, Motta M, Giussani C, Gobbin G, Taverna M, D'Alessio A. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report. BMC Infect Dis 2021;21:811. [PMID: 34388982 DOI: 10.1186/s12879-021-06532-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 153 |
Nakatsutsumi K, Endo A, Okuzawa H, Onishi I, Koyanagi A, Nagaoka E, Morishita K, Aiboshi J, Otomo Y. Colon perforation as a complication of COVID-19: a case report. Surg Case Rep 2021;7:175. [PMID: 34347185 DOI: 10.1186/s40792-021-01261-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 154 |
de Cortina Camarero C, Gómez Mariscal E, Espejo Bares V, Núñez Garcia A, Muñoz Aguilera R, Botas Rodriguez J. SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome. Medicina Clínica (English Edition) 2021;157:114-117. [DOI: 10.1016/j.medcle.2021.01.012] [Reference Citation Analysis]
|
| 155 |
Levy JH, Iba T, Olson LB, Corey KM, Ghadimi K, Connors JM. COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations. Int J Lab Hematol 2021;43 Suppl 1:29-35. [PMID: 34288441 DOI: 10.1111/ijlh.13500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 156 |
Sandoval M, Nguyen DT, Vahidy FS, Graviss EA. Risk factors for severity of COVID-19 in hospital patients age 18-29 years. PLoS One 2021;16:e0255544. [PMID: 34329347 DOI: 10.1371/journal.pone.0255544] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 157 |
Sharma S, Wood M, Gulli G. COVID-19-associated ischaemic stroke despite use of anticoagulation. BMJ Case Rep 2021;14:e243741. [PMID: 34326115 DOI: 10.1136/bcr-2021-243741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 158 |
Ceci Bonello E, Casha R, Xerri T, Bonello J, Fsadni C, Mallia Azzopardi C. Multiorgan thrombosis as a complication of COVID-19 pneumonia. BMJ Case Rep 2021;14:e243953. [PMID: 34321271 DOI: 10.1136/bcr-2021-243953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 159 |
Moubarak M, Kasozi KI, Hetta HF, Shaheen HM, Rauf A, Al-Kuraishy HM, Qusti S, Alshammari EM, Ayikobua ET, Ssempijja F, Afodun AM, Kenganzi R, Usman IM, Ochieng JJ, Osuwat LO, Matama K, Al-Gareeb AI, Kairania E, Musenero M, Welburn SC, Batiha GE. The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections. Life (Basel) 2021;11:734. [PMID: 34440478 DOI: 10.3390/life11080734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 160 |
Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol 2021;99:107995. [PMID: 34304001 DOI: 10.1016/j.intimp.2021.107995] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 161 |
Go AS, Reynolds K, Tabada GH, Prasad PA, Sung SH, Garcia E, Portugal C, Fan D, Pai AP, Fang MC. COVID-19 and Risk of VTE in Ethnically Diverse Populations. Chest 2021:S0012-3692(21)01353-2. [PMID: 34293316 DOI: 10.1016/j.chest.2021.07.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 162 |
Prokop JW, Hartog NL, Chesla D, Faber W, Love CP, Karam R, Abualkheir N, Feldmann B, Teng L, McBride T, Leimanis ML, English BK, Holsworth A, Frisch A, Bauss J, Kalpage N, Derbedrossian A, Pinti RM, Hale N, Mills J, Eby A, VanSickle EA, Pageau SC, Shankar R, Chen B, Carcillo JA, Sanfilippo D, Olivero R, Bupp CP, Rajasekaran S. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals. Front Immunol 2021;12:694243. [PMID: 34335605 DOI: 10.3389/fimmu.2021.694243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 163 |
García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ, Vílchez JA, Bauça JM, Alcaide Martín MJ, Gutiérrez Garcia I, de la Hera Cagigal P, Egea-Caparrós JM, Pérez Sanmartín S, Gutiérrez Revilla JI, Urrechaga E, Álamo JM, Hernando Holgado AM, Lorenzo-Lozano MC, Canalda Campás M, Juncos Tobarra MA, Morales-Indiano C, Vírseda Chamorro I, Pastor Murcia Y, Sahuquillo Frías L, Altimira Queral L, Nuez-Zaragoza E, Adell Ruiz de León J, Ruiz Ripa A, Salas Gómez-Pablos P, Cebreiros López I, Fernández Uriarte A, Larruzea A, López Yepes ML, Sancho-Rodríguez N, Zamorano Andrés MC, Pedregosa Díaz J, Sáenz L, Esparza Del Valle C, Baamonde Calzada MC, García Muñoz S, Vera M, Martín Torres E, Sánchez Fdez-Pacheco S, Vicente Gutiérrez L, Jiménez Añón L, Pérez Martínez A, Pons Castillo A, González Tamayo R, Férriz Vivancos J, Rodríguez-Fraga O, Díaz-Brito V, Aguadero V, García Arévalo MG, Arnaldos Carrillo M, González Morales M, Núñez Gárate M, Ruiz Iruela C, Esteban Torrella P, Vila Pérez M, Acevedo Alcaraz C, Blázquez-Manzanera AL, Galán Ortega A. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study). J Thromb Thrombolysis 2021. [PMID: 34272635 DOI: 10.1007/s11239-021-02527-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 164 |
Fenyves BG, Mehta A, Kays KR, Goldberg MB, Hacohen N, Filbin MR; MGH COVID-19 Collection & Processing Team. Plasma P-selectin is an early marker of thromboembolism in COVID-19. medRxiv 2021:2021. [PMID: 34282425 DOI: 10.1101/2021.07.10.21260293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 165 |
Stelzer M, Henes J, Saur S. The Role of Antiphospholipid Antibodies in COVID-19. Curr Rheumatol Rep 2021;23:72. [PMID: 34259944 DOI: 10.1007/s11926-021-01041-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 166 |
Bayrak M, Çadirci K. Mortal disseminated intravascular coagulopathy and cutaneous involvement in a COVID-19 positive patient; case report. Anatolian Current Medical Journal 2021;3:259-261. [DOI: 10.38053/acmj.930047] [Reference Citation Analysis]
|
| 167 |
Kalafatis M. Covid-19: A Serious Vascular Disease With Primary Symptoms Of A Respiratory Ailment. J Appl Lab Med 2021:jfab084. [PMID: 34240194 DOI: 10.1093/jalm/jfab084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 168 |
Sandor-Keri J, Benedek I, Polexa S, Benedek I. The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality. J Clin Med 2021;10:3015. [PMID: 34300181 DOI: 10.3390/jcm10143015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 169 |
Sharathkumar AA, Faustino EVS, Takemoto CM. How we approach thrombosis risk in children with COVID-19 infection and MIS-C. Pediatr Blood Cancer 2021;68:e29049. [PMID: 33955167 DOI: 10.1002/pbc.29049] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 170 |
Abdeen S, Bdeir K, Abu-Fanne R, Maraga E, Higazi M, Khurram N, Feldman M, Deshpande C, Litzky LA, Heyman SN, Montone KT, Cines DB, Higazi AA. Alpha-defensins: risk factor for thrombosis in COVID-19 infection. Br J Haematol 2021;194:44-52. [PMID: 34053084 DOI: 10.1111/bjh.17503] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 171 |
Dhar S, Bhattacharjee P. Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation. J Funct Foods 2021;82:104503. [PMID: 33897833 DOI: 10.1016/j.jff.2021.104503] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 172 |
Emmenegger M, Saseendran Kumar S, Emmenegger V, Malinauskas T, Büttner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.. [DOI: 10.1101/2021.06.21.449211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 173 |
Matli K, Farah R, Maalouf M, Chamoun N, Costanian C, Ghanem G. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021;8:e001628. [PMID: 34099529 DOI: 10.1136/openhrt-2021-001628] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 174 |
Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal. bioRxiv 2021:2021. [PMID: 34127975 DOI: 10.1101/2021.06.07.447287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 175 |
Chashchin MG, Gorshkov AY, Drapkina OM. Acute coronary syndrome in COVID-19 patients. Cardiovasc Ther Prev 2021;20:2806. [DOI: 10.15829/1728-8800-2021-2806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 176 |
Kantarcioglu B, Iqbal O, Walenga JM, Lewis B, Lewis J, Carter CA, Singh M, Lievano F, Tafur A, Ramacciotti E, Gerotziafas GT, Jeske W, Fareed J. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clin Appl Thromb Hemost 2021;27:10760296211021498. [PMID: 34060379 DOI: 10.1177/10760296211021498] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 177 |
Schulze-Schiappacasse C, Alarcón-Andrade G, Valenzuela G, Ferreiro M, Cavagnaro A, García-Salum T, Gutiérrez M, Medina RA. Pulmonary Artery Thrombosis in a Newborn With Severe Coronavirus Disease 2019. Pediatr Infect Dis J 2021;40:e252-4. [PMID: 33956761 DOI: 10.1097/INF.0000000000003131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 178 |
Nassar AH, Maselli AM, Dowlatshahi AS. Microvascular free tissue transfer in the setting of COVID-19 associated coagulopathy: A case report. Orthoplastic Surgery 2021;4:20-22. [DOI: 10.1016/j.orthop.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 179 |
Levi M. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19. Hemasphere 2021;5:e571. [PMID: 34095755 DOI: 10.1097/HS9.0000000000000571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 180 |
Zhang J, Huang X, Ding D, Tao Z. Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases. Exp Hematol Oncol 2021;10:34. [PMID: 34059141 DOI: 10.1186/s40164-021-00228-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 181 |
de Almeida DC, Franco MDCP, Dos Santos DRP, Santos MC, Maltoni IS, Mascotte F, de Souza AA, Pietrobom PM, Medeiros EA, Ferreira PRA, Machado FR, Goes MA. Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients. PLoS One 2021;16:e0251048. [PMID: 34033655 DOI: 10.1371/journal.pone.0251048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 182 |
Goswami J, MacArthur TA, Sridharan M, Pruthi RK, McBane RD 2nd, Witzig TE, Park MS. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy. Shock 2021;55:700-16. [PMID: 33378321 DOI: 10.1097/SHK.0000000000001680] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 183 |
Siepmann T, Barlinn K. [Association of COVID-19 and Stroke: Pathophysiology and Clinical Relevance]. Fortschr Neurol Psychiatr 2021;89:289-95. [PMID: 34020462 DOI: 10.1055/a-1484-0224] [Reference Citation Analysis]
|
| 184 |
Arifputra J, Haroen H, Rotty LWA, Lasut PFC, Hendratta C. Coagulopathy of Coronavirus Disease 2019: A Case Series. Open Access Maced J Med Sci 2020;9:301-7. [DOI: 10.3889/oamjms.2021.6026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 185 |
Xiong Y, Ma Y, Tian Y, Zhang C, Yang W, Liu B, Ruan L, Lu C, Huang L. A Longitudinal Cohort Study Using a Modified Child-Pugh Score to Escalate Respiratory Support in COVID-19 Patients - Hubei Province, China, 2020. China CDC Wkly 2021;3:423-9. [PMID: 34594905 DOI: 10.46234/ccdcw2021.113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 186 |
Aribawa IGNM, Hidayat L, Dewi PU, Ryalino C. Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis. Am J Case Rep 2021;22:e930667. [PMID: 33967265 DOI: 10.12659/AJCR.930667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 187 |
McAlpine LS, Zubair AS, Maran I, Chojecka P, Lleva P, Jasne AS, Navaratnam D, Matouk C, Schindler J, Sheth KN, Chun H, Lee AI, Spudich S, Sharma R, Sansing LH. Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients. Stroke 2021;52:e233-8. [PMID: 33966492 DOI: 10.1161/STROKEAHA.120.031971] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 188 |
Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021;9:622-42. [PMID: 33965003 DOI: 10.1016/S2213-2600(21)00218-6] [Cited by in Crossref: 181] [Cited by in F6Publishing: 129] [Article Influence: 90.5] [Reference Citation Analysis]
|
| 189 |
Kofteridis DP, Ioannou P, Kondili E, Chamilos G, Filippatos TD. Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 - The role of anti-Xa monitoring. Clin Microbiol Infect 2021;27:1188-9. [PMID: 33933565 DOI: 10.1016/j.cmi.2021.04.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 190 |
Стрельченя О, Стрельченя Т. КОАГУЛОПАТІЯ У ПАЦІЄНТІВ З COVID-19. journal 2021. [DOI: 10.32839/2304-5809/2021-4-92-3] [Reference Citation Analysis]
|
| 191 |
Mei ZW, van Wijk XMR, Pham HP, Marin MJ. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. J Appl Lab Med 2021:jfab042. [PMID: 33930144 DOI: 10.1093/jalm/jfab042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 192 |
Sayed Ahmed HA, Merrell E, Ismail M, Joudeh AI, Riley JB, Shawkat A, Habeb H, Darling E, Goweda RA, Shehata MH, Amin H, Nieman GF, Aiash H. Rationales and uncertainties for aspirin use in COVID-19: a narrative review. Fam Med Community Health 2021;9:e000741. [PMID: 33879541 DOI: 10.1136/fmch-2020-000741] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 193 |
Reisi-Vanani V, Lorigooini Z, Dayani MA, Mardani M, Rahmani F. Massive intraperitoneal hemorrhage in patients with COVID-19: a case series. J Thromb Thrombolysis 2021;52:338-44. [PMID: 33909261 DOI: 10.1007/s11239-021-02447-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 194 |
Ahmed M, Gaba WH, Al Mazrouei SS. Neuro-imaging manifestations of COVID-19: Predilection for PICA infarcts. IDCases 2021;24:e01131. [PMID: 33898251 DOI: 10.1016/j.idcr.2021.e01131] [Reference Citation Analysis]
|
| 195 |
Leentjens J, van Haaps TF, Wessels PF, Schutgens REG, Middeldorp S. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year. Lancet Haematol 2021;8:e524-33. [PMID: 33930350 DOI: 10.1016/S2352-3026(21)00105-8] [Cited by in Crossref: 98] [Cited by in F6Publishing: 115] [Article Influence: 49.0] [Reference Citation Analysis]
|
| 196 |
Wang R, Hu Q, Wang H, Zhu G, Wang M, Zhang Q, Zhao Y, Li C, Zhang Y, Ge G, Chen H, Chen L. Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro. Int J Biol Macromol 2021;183:182-92. [PMID: 33901557 DOI: 10.1016/j.ijbiomac.2021.04.129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 197 |
Zhao B, Liu M, Liu P, Peng Y, Huang J, Li M, Wang Y, Xu L, Sun S, Qi X, Ling Y, Li J, Zhang W, Mao E, Qu J. High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study. Front Pharmacol 2021;12:638556. [PMID: 33967773 DOI: 10.3389/fphar.2021.638556] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 198 |
Schmid A, Petrovic M, Akella K, Pareddy A, Velavan SS. Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19. Int J Vasc Med 2021;2021:6693895. [PMID: 34035963 DOI: 10.1155/2021/6693895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 199 |
Shah A, Dave S, Galvagno S, George K, Menne AR, Haase DJ, McCormick B, Rector R, Dahi S, Madathil RJ, Deatrick KB, Ghoreishi M, Gammie JS, Kaczorowski DJ, Scalea TM, Menaker J, Herr D, Tabatabai A, Krause E. A Dedicated Veno-Venous Extracorporeal Membrane Oxygenation Unit during a Respiratory Pandemic: Lessons Learned from COVID-19 Part II: Clinical Management. Membranes (Basel) 2021;11:306. [PMID: 33919390 DOI: 10.3390/membranes11050306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 200 |
An OI, Martyanov AA, Stepanyan MG, Boldova AE, Rumyantsev SA, Panteleev MA, Ataullakhanov FI, Rumyantsev AG, Sveshnikova AN. Platelets in COVID-19: “innocent by-standers” or active participants? Voprosy gematologii/onkologii i immunopatologii v pediatrii 2021;20:184-191. [DOI: 10.24287/1726-1708-2021-20-1-184-191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 201 |
Afari H, Tefera L, Rosovsky RP. Case of right ventricular and aortic thrombi in a patient with severe COVID-19. BMJ Case Rep 2021;14:e240745. [PMID: 33875503 DOI: 10.1136/bcr-2020-240745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 202 |
Demeulemeester F, de Punder K, van Heijningen M, van Doesburg F. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review. Cells 2021;10:933. [PMID: 33920604 DOI: 10.3390/cells10040933] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 203 |
Ten Cate H, Leader A. Management of Disseminated Intravascular Coagulation in Acute Leukemias. Hamostaseologie 2021;41:120-6. [PMID: 33860520 DOI: 10.1055/a-1393-8302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 204 |
LaFond E, Weidman K, Lief L. Care of the postcoronavirus disease 2019 patient. Curr Opin Pulm Med 2021;27:199-204. [PMID: 33606410 DOI: 10.1097/MCP.0000000000000767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 205 |
Ray JG, Vermeulen MJ, Schull MJ, Park AL. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study. Clin Appl Thromb Hemost 2021;27:10760296211008986. [PMID: 33827287 DOI: 10.1177/10760296211008986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 206 |
Saha A, Bajpai A, Krishna V, Bhattacharya S. Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel) 2021;21:2636. [PMID: 33918646 DOI: 10.3390/s21082636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 207 |
Anwar N, Tashfeen S, Akhtar F, Noor A, Khan SA, Omair A. Can disseminated intravascular coagulation scores predict mortality in COVID-19 patients? J Taibah Univ Med Sci 2021;16:596-604. [PMID: 33850513 DOI: 10.1016/j.jtumed.2021.03.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 208 |
de la Morena-Barrio ME, Bravo-Pérez C, Miñano A, de la Morena-Barrio B, Fernandez-Perez MP, Bernal E, Gómez-Verdu JM, Herranz MT, Vicente V, Corral J, Lozano ML. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients. Sci Rep 2021;11:7792. [PMID: 33833254 DOI: 10.1038/s41598-021-85906-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 209 |
Faqihi F, Alharthy A, Abdulaziz S, Balhamar A, Alomari A, AlAseri Z, Tamim H, Alqahtani SA, Kutsogiannis DJ, Brindley PG, Karakitsos D, Memish ZA. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial. Int J Antimicrob Agents 2021;57:106334. [PMID: 33838224 DOI: 10.1016/j.ijantimicag.2021.106334] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 210 |
Beaulieu MC, Mettelus DS, Rioux-Massé B, Mahone M. Thrombotic thrombocytopenic purpura as the initial presentation of COVID-19. J Thromb Haemost 2021;19:1132-4. [PMID: 33382912 DOI: 10.1111/jth.15231] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 211 |
Melegari G, Rivi V, Zelent G, Nasillo V, De Santis E, Melegari A, Bevilacqua C, Zoli M, Meletti S, Barbieri A. Mild to Severe Neurological Manifestations of COVID-19: Cases Reports. Int J Environ Res Public Health 2021;18:3673. [PMID: 33915937 DOI: 10.3390/ijerph18073673] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 212 |
Levy JH, Iba T, Gardiner EE. Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together. Arterioscler Thromb Vasc Biol 2021;41:1774-6. [PMID: 33792345 DOI: 10.1161/ATVBAHA.121.316101] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 213 |
Aghayari Sheikh Neshin S, Shahjouei S, Koza E, Friedenberg I, Khodadadi F, Sabra M, Kobeissy F, Ansari S, Tsivgoulis G, Li J, Abedi V, Wolk DM, Zand R. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front Cardiovasc Med 2021;8:649922. [PMID: 33855053 DOI: 10.3389/fcvm.2021.649922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 214 |
D'Elia E, Gori M, Grosu A, Iorio A, Lorini FL, Falanga A, Di Marco F, Senni M. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug. BMC Pulm Med 2021;21:102. [PMID: 33761886 DOI: 10.1186/s12890-021-01453-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 215 |
Matli K, Farah R, Maalouf M, Costanian C, Chamoun N, Ghanem G. Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review.. [DOI: 10.1101/2021.03.21.21253754] [Reference Citation Analysis]
|
| 216 |
Alabyad D, Rangaraju S, Liu M, Imran R, Kempton CL, Sharifpour M, Auld SC, Gaddh M, Sniecinski R, Maier CL, Guarner J, Duncan A, Nahab F. Validation of an admission coagulation panel for risk stratification of COVID-19 patients. PLoS One 2021;16:e0248230. [PMID: 33740793 DOI: 10.1371/journal.pone.0248230] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 217 |
Saiganov SA, Mazurov VI, Melnikov ES, Latariia EL. Possibilities of janus kinase inhibitors application in complex treatment of patients with COVID-19. HERALD of North-Western State Medical University named after I I Mechnikov 2021;12:15-24. [DOI: 10.17816/mechnikov45894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 218 |
Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy. Expert Rev Respir Med 2021;15:1003-11. [PMID: 33667146 DOI: 10.1080/17476348.2021.1899815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 219 |
Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Naučno-praktičeskaâ revmatologiâ 2021;59:5-30. [DOI: 10.47360/1995-4484-2021-5-30] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 220 |
Babaei MR, Mohammadi-vajari M, Mohammadi-vajari E, Assistant Professor of Radiology, Fellowship of Interventional Radiology, Department of Radiology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran, Radiology Resident, Department of Radiology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran, Medical Student, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. Coagulopathy in COVID-19 Patients and Endovascular Treatment, Reports of 4 Patients. Iran J Med Microbiol 2021;15:257-265. [DOI: 10.30699/ijmm.15.2.257] [Reference Citation Analysis]
|
| 221 |
Zhang P, Heyman T, Greechan M, Dygulska B, Al Sayyed F, Narula P, Lederman S. Maternal, neonatal and placental characteristics of SARS-CoV-2 positive mothers. The Journal of Maternal-Fetal & Neonatal Medicine. [DOI: 10.1080/14767058.2021.1892637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 222 |
Goudarzi S, Firouzabadi FD, Mahmoudzadeh F, Aminimoghaddam S. Pulmonary embolism in pregnancy with COVID-19 infection: A case report. Clin Case Rep 2021. [PMID: 33821188 DOI: 10.1002/ccr3.3709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 223 |
Olwal CO, Nganyewo NN, Tapela K, Djomkam Zune AL, Owoicho O, Bediako Y, Duodu S. Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19. Front Immunol 2021;12:602848. [PMID: 33613574 DOI: 10.3389/fimmu.2021.602848] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 224 |
Guervilly C, Bonifay A, Burtey S, Sabatier F, Cauchois R, Abdili E, Arnaud L, Lano G, Pietri L, Robert T, Velier M, Papazian L, Albanese J, Kaplanski G, Dignat-George F, Lacroix R. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv 2021;5:628-34. [PMID: 33560376 DOI: 10.1182/bloodadvances.2020003308] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 26.5] [Reference Citation Analysis]
|
| 225 |
Comer SP, Cullivan S, Szklanna PB, Weiss L, Cullen S, Kelliher S, Smolenski A, Murphy C, Altaie H, Curran J, O'Reilly K, Cotter AG, Marsh B, Gaine S, Mallon P, McCullagh B, Moran N, Ní Áinle F, Kevane B, Maguire PB; COCOON Study investigators. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol 2021;19:e3001109. [PMID: 33596198 DOI: 10.1371/journal.pbio.3001109] [Cited by in Crossref: 69] [Cited by in F6Publishing: 76] [Article Influence: 34.5] [Reference Citation Analysis]
|
| 226 |
Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy. Atherosclerosis 2021;322:39-50. [PMID: 33706082 DOI: 10.1016/j.atherosclerosis.2021.02.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 227 |
Falter T, Rossmann H, Menge P, Goetje J, Groenwoldt S, Weinmann A, Sivanathan V, Schulz A, Lemmermann NAW, Danckwardt S, Lackner KJ, Galle PR, Scharrer I, Lämmle B, Sprinzl MF. No Evidence for Classic Thrombotic Microangiopathy in COVID-19. J Clin Med 2021;10:671. [PMID: 33572417 DOI: 10.3390/jcm10040671] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 228 |
Assinger A. COVID-19-related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy. Res Pract Thromb Haemost 2021;5:11-3. [PMID: 33537524 DOI: 10.1002/rth2.12473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 229 |
Campello E, Bulato C, Spiezia L, Boscolo A, Poletto F, Cola M, Gavasso S, Simion C, Radu CM, Cattelan A, Tiberio I, Vettor R, Navalesi P, Simioni P. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis. Clin Chem Lab Med 2021;59:1323-30. [PMID: 33544518 DOI: 10.1515/cclm-2021-0108] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 230 |
Dignat-george F, Bonifay A, Lacroix R. Les microvésicules cellulaires : biomarqueurs émergents en pathologie cardiovasculaire : intérêt dans le risque thrombotique de la COVID 19. Bulletin de l'Académie Nationale de Médecine 2021;205:166-179. [DOI: 10.1016/j.banm.2020.04.016] [Reference Citation Analysis]
|
| 231 |
Safak S, Aksoy E, Dirim AB, Demir E, Garayeva N, Oto OA, Artan AS, Yazici H, Besisik S, Turkmen A. Successful treatment of a COVID-19 patient with thrombotic microangiopathy. Clin Kidney J 2021;14:1287-8. [PMID: 34094522 DOI: 10.1093/ckj/sfab024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 232 |
Shankar A, Varadan B, Ethiraj D, Sudarsanam H, Hakeem AR, Kalyanasundaram S. Systemic arterio-venous thrombosis in COVID-19: A pictorial review. World J Radiol 2021; 13(1): 19-28 [PMID: 33574991 DOI: 10.4329/wjr.v13.i1.19] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 233 |
de Cortina Camarero C, Gómez Mariscal E, Espejo Bares V, Núñez Garcia A, Muñoz Aguilera R, Botas Rodriguez J. [SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome]. Med Clin (Barc) 2021;157:114-7. [PMID: 33632511 DOI: 10.1016/j.medcli.2021.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 234 |
Tomo S, Kumar KP, Roy D, Sankanagoudar S, Purohit P, Yadav D, Banerjee M, Sharma P, Misra S. Complement activation and coagulopathy - an ominous duo in COVID19. Expert Rev Hematol 2021;14:155-73. [PMID: 33480807 DOI: 10.1080/17474086.2021.1875813] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 235 |
Iba T, Connors JM, Spyropoulos AC, Wada H, Levy JH. Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? Int J Hematol 2021;113:330-6. [PMID: 33471294 DOI: 10.1007/s12185-021-03078-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 236 |
Habashi NM, Camporota L, Gatto LA, Nieman G. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications. J Appl Physiol (1985) 2021;130:877-91. [PMID: 33444117 DOI: 10.1152/japplphysiol.00742.2020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 237 |
Bastopcu M. Extensive Arterial Thrombus Following Discharge after a Covid-19 Infection. Ann Vasc Surg 2021;72:205-8. [PMID: 33333188 DOI: 10.1016/j.avsg.2020.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 238 |
Melgaço JG, Brito E Cunha D, Azamor T, da Silva AMV, Tubarão LN, Gonçalves RB, Monteiro RQ, Missailidis S, da Costa Neves PC, Ano Bom APD. Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs. J Immunol Res 2020;2020:8827670. [PMID: 33426096 DOI: 10.1155/2020/8827670] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 239 |
Faqihi F, Alharthy A, Balhamar A, Nasim N, Alanezi K, Alaklobi F, Memish ZA, Blaivas M, Alqahtani SA, Karakitsos D. A Retrospective Analysis of Thromboembolic Phenomena in Mechanically Ventilated Patients with COVID-19. Crit Care Res Pract 2021;2021:8737580. [PMID: 33520314 DOI: 10.1155/2021/8737580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 240 |
Voicu S, Ketfi C, Stépanian A, Chousterman BG, Mohamedi N, Siguret V, Mebazaa A, Mégarbane B, Bonnin P. Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients. Front Physiol 2020;11:608788. [PMID: 33488398 DOI: 10.3389/fphys.2020.608788] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 241 |
Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol 2021;100:309-20. [PMID: 33415422 DOI: 10.1007/s00277-020-04366-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 242 |
Iba T, Warkentin TE, Thachil J, Levi M, Levy JH. Proposal of the Definition for COVID-19-Associated Coagulopathy. J Clin Med 2021;10:E191. [PMID: 33430431 DOI: 10.3390/jcm10020191] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 23.5] [Reference Citation Analysis]
|
| 243 |
Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 2021;76:412-20. [PMID: 33408195 DOI: 10.1136/thoraxjnl-2020-216243] [Cited by in Crossref: 122] [Cited by in F6Publishing: 132] [Article Influence: 61.0] [Reference Citation Analysis]
|
| 244 |
Kamit F, Malbora B, Atay A, Bayirli DT, Bektas M. A Fatal Case of COVID-19 in a Child with ALL: A Cytokine Storm and Hyperferritinemic MODS. Journal of Child Science 2020;10:e240-5. [DOI: 10.1055/s-0040-1721513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 245 |
Cabrera-garcia D, Miltiades A, Parsons S, Elisman K, Mansouri MT, Wagener G, Harrison NL. High levels of plasminogen activator inhibitor-1, tissue plasminogen activator and fibrinogen in patients with severe COVID-19.. [DOI: 10.1101/2020.12.29.20248869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 246 |
Waters J, Spiegel R, Mccurdy MT. Hematologic Emergencies in Patients with Covid-19. Critical Care of COVID-19 in the Emergency Department 2021. [DOI: 10.1007/978-3-030-85636-6_13] [Reference Citation Analysis]
|
| 247 |
Fernández-Sarmiento J, De Souza D, Jabornisky R, Gonzalez GA, Arias López MDP, Palacio G. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee. BMJ Paediatr Open 2021;5:e000894. [PMID: 34192188 DOI: 10.1136/bmjpo-2020-000894] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 248 |
Thachil J. D-Dimer and thrombosis in COVID-19. Indian J Vasc Endovasc Surg 2021;8:6. [DOI: 10.4103/ijves.ijves_67_21] [Reference Citation Analysis]
|
| 249 |
Otsubo S, Aoyama Y, Kinoshita K, Wakabayashi S, Otsubo Y. Characteristics of COVID‒19 in hemodialysis patients. Nihon Toseki Igakkai Zasshi 2021;54:441-448. [DOI: 10.4009/jsdt.54.441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 250 |
Umemura Y. Hematological phenotype of COVID-19-induced coagulopathy: Far from typical sepsis-induced coagulopathy. Nihon Kessen Shiketsu Gakkaishi 2021;32:51-54. [DOI: 10.2491/jjsth.32.51] [Reference Citation Analysis]
|
| 251 |
Bukva M, Islamović M, Jusufović S, Njemčević E, Meseldžić N, Bego T. The Most Significant Biomarkers and Specific Antibodies for the Early Diagnosis and Monitoring in COVID-19 Patients. IFMBE Proceedings 2021. [DOI: 10.1007/978-3-030-73909-6_95] [Reference Citation Analysis]
|
| 252 |
Romaszko-wojtowicz AM, Doboszyńska A. Pulmonary complications due to COVID-19 – a literature review. Pol Ann Med 2021. [DOI: 10.29089/2021.21.00181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 253 |
Park J, Kim H, Kim SY, Kim Y, Lee JS, Dan K, Seong MW, Han D. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients. Sci Rep 2020;10:22418. [PMID: 33376242 DOI: 10.1038/s41598-020-80120-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 254 |
Vavougios GD, Ntoskas KT, Doskas TK. Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients. Med Hypotheses 2021;147:110475. [PMID: 33421689 DOI: 10.1016/j.mehy.2020.110475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 255 |
Delrue M, Siguret V, Neuwirth M, Joly B, Beranger N, Sène D, Chousterman BG, Voicu S, Bonnin P, Mégarbane B, Stépanian A. von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients. Br J Haematol 2021;192:1097-100. [PMID: 33368196 DOI: 10.1111/bjh.17216] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 256 |
Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther 2020;5:293. [PMID: 33361764 DOI: 10.1038/s41392-020-00454-7] [Cited by in Crossref: 195] [Cited by in F6Publishing: 204] [Article Influence: 65.0] [Reference Citation Analysis]
|
| 257 |
Waite AAC, Hamilton DO, Pizzi R, Ageno W, Welters ID. Hypercoagulopathy in Severe COVID-19: Implications for Acute Care. Thromb Haemost 2020;120:1654-67. [PMID: 33368088 DOI: 10.1055/s-0040-1721487] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 258 |
Christie F, Quasim T, Cowan R, King K, McPeake J. Meralgia paraesthetica in intensive care unit survivors of COVID-19. Anaesthesia 2021;76:712-3. [PMID: 33351958 DOI: 10.1111/anae.15355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 259 |
Tsivgoulis G, Palaiodimou L, Zand R, Lioutas VA, Krogias C, Katsanos AH, Shoamanesh A, Sharma VK, Shahjouei S, Baracchini C, Vlachopoulos C, Gournellis R, Sfikakis PP, Sandset EC, Alexandrov AV, Tsiodras S. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord 2020;13:1756286420978004. [PMID: 33343709 DOI: 10.1177/1756286420978004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 260 |
Robinson PC, Liew DFL, Liew JW, Monaco C, Richards D, Shivakumar S, Tanner HL, Feldmann M. The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19. Med (N Y) 2020;1:90-102. [PMID: 33294881 DOI: 10.1016/j.medj.2020.11.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 261 |
Nazarko L. Clinical update. Nursing and Residential Care 2020;22:1-2. [DOI: 10.12968/nrec.2020.22.12.2b] [Reference Citation Analysis]
|
| 262 |
Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, Rimmelé T, Zarbock A, Bell S, Bihorac A, Cantaluppi V, Hoste E, Husain-Syed F, Germain MJ, Goldstein SL, Gupta S, Joannidis M, Kashani K, Koyner JL, Legrand M, Lumlertgul N, Mohan S, Pannu N, Peng Z, Perez-Fernandez XL, Pickkers P, Prowle J, Reis T, Srisawat N, Tolwani A, Vijayan A, Villa G, Yang L, Ronco C, Kellum JA. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 2020;16:747-64. [PMID: 33060844 DOI: 10.1038/s41581-020-00356-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 263 |
Smorenberg A, Peters EJ, van Daele P, Nossent EJ, Muller M. How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. Eur J Intern Med 2021;83:1-5. [PMID: 33303345 DOI: 10.1016/j.ejim.2020.11.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 264 |
Criado PR, Miot HA, Pincelli TPH, Fabro AT. From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatol Ther 2021;34:e14565. [PMID: 33219572 DOI: 10.1111/dth.14565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 265 |
Desai AD, Boursiquot BC, Melki L, Wan EY. Management of Arrhythmias Associated with COVID-19. Curr Cardiol Rep 2020;23:2. [PMID: 33231782 DOI: 10.1007/s11886-020-01434-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 266 |
Pretorius E, Venter C, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB. Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report. Cardiovasc Diabetol 2020;19:193. [PMID: 33203441 DOI: 10.1186/s12933-020-01165-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 267 |
Bell R, Zini G, d'Onofrio G, Rogers HJ, Lee YS, Frater JL. The hematology laboratory's response to the COVID-19 pandemic: A scoping review. Int J Lab Hematol. 2021;43:148-159. [PMID: 33180380 DOI: 10.1111/ijlh.13381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 268 |
Mehta JL, Calcaterra G, Bassareo PP. COVID-19, thromboembolic risk, and Virchow's triad: Lesson from the past. Clin Cardiol 2020;43:1362-7. [PMID: 33176009 DOI: 10.1002/clc.23460] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 269 |
Al-Subaie AM. Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists. Saudi J Biol Sci 2021;28:956-61. [PMID: 33169062 DOI: 10.1016/j.sjbs.2020.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 270 |
Venter C, Bezuidenhout JA, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19. Int J Mol Sci 2020;21:E8234. [PMID: 33153161 DOI: 10.3390/ijms21218234] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 271 |
Zhang A, Leng Y, Zhang Y, Wu K, Ji Y, Lei S, Xia Z. Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19. Int J Infect Dis 2020;100:441-8. [PMID: 32947052 DOI: 10.1016/j.ijid.2020.09.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 272 |
Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, López-Fernández T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement. CA Cancer J Clin 2020;70:480-504. [PMID: 32910493 DOI: 10.3322/caac.21635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 273 |
Ostaszewski M, Niarakis A, Mazein A, Kuperstein I, Phair R, Orta-resendiz A, Singh V, Aghamiri SS, Acencio ML, Glaab E, Ruepp A, Fobo G, Montrone C, Brauner B, Frishman G, Cristóbal Monraz Gómez L, Somers J, Hoch M, Gupta SK, Scheel J, Borlinghaus H, Czauderna T, Schreiber F, Montagud A, Leon MPD, Funahashi A, Hiki Y, Hiroi N, Yamada TG, Dräger A, Renz A, Naveez M, Bocskei Z, Messina F, Börnigen D, Fergusson L, Conti M, Rameil M, Nakonecnij V, Vanhoefer J, Schmiester L, Wang M, Ackerman EE, Shoemaker J, Zucker J, Oxford K, Teuton J, Kocakaya E, Yağmur Summak G, Hanspers K, Kutmon M, Coort S, Eijssen L, Ehrhart F, Rex DAB, Slenter D, Martens M, Pham N, Haw R, Jassal B, Matthews L, Orlic-milacic M, Ribeiro AS, Rothfels K, Shamovsky V, Stephan R, Sevilla C, Varusai T, Ravel J, Fraser R, Ortseifen V, Marchesi S, Gawron P, Smula E, Heirendt L, Satagopam V, Wu G, Riutta A, Golebiewski M, Owen S, Goble C, Hu X, Overall RW, Maier D, Bauch A, Gyori BM, Bachman JA, Vega C, Grouès V, Vazquez M, Porras P, Licata L, Iannuccelli M, Sacco F, Nesterova A, Yuryev A, Waard AD, Turei D, Luna A, Babur O, Soliman S, Valdeolivas A, Medina ME, Peña-chilet M, Rian K, Helikar T, Puniya BL, Modos D, Treveil A, Olbei M, Meulder BD, Dugourd A, Naldi A, Noë V, Calzone L, Sander C, Demir E, Korcsmaros T, Freeman TC, Augé F, Beckmann JS, Hasenauer J, Wolkenhauer O, Wilighagen EL, Pico AR, Evelo CT, Gillespie ME, Stein LD, Hermjakob H, D’eustachio P, Saez-rodriguez J, Dopazo J, Valencia A, Kitano H, Barillot E, Auffray C, Balling R, Schneider R, the COVID-19 Disease Map Community. COVID-19 Disease Map, a computational knowledge repository of SARS-CoV-2 virus-host interaction mechanisms.. [DOI: 10.1101/2020.10.26.356014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 274 |
Silva TF, Tomiotto-Pellissier F, Sanfelice RA, Gonçalves MD, da Silva Bortoleti BT, Detoni MB, Rodrigues ACJ, Carloto ACM, Concato VM, Siqueira EDS, Costa IN, Pavanelli WR, Conchon-Costa I, Miranda-Sapla MM. A 21st Century Evil: Immunopathology and New Therapies of COVID-19. Front Immunol 2020;11:562264. [PMID: 33193331 DOI: 10.3389/fimmu.2020.562264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 275 |
Elbeddini A, Gerochi R, Elshahawi A. Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy. J Pharm Policy Pract 2020;13:73. [PMID: 33117545 DOI: 10.1186/s40545-020-00274-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 276 |
Galstyan GM. Coagulopathy in COVID-19. Pulʹmonologiâ (Mosk ) 2020;30:645-657. [DOI: 10.18093/0869-0189-2020-30-5-645-657] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 277 |
Daher A, Balfanz P, Cornelissen C, Müller A, Bergs I, Marx N, Müller-Wieland D, Hartmann B, Dreher M, Müller T. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med 2020;174:106197. [PMID: 33120193 DOI: 10.1016/j.rmed.2020.106197] [Cited by in Crossref: 127] [Cited by in F6Publishing: 139] [Article Influence: 42.3] [Reference Citation Analysis]
|
| 278 |
Mongula JE, Frenken MWE, van Lijnschoten G, Arents NLA, de Wit-Zuurendonk LD, Schimmel-de Kok APA, van Runnard Heimel PJ, Porath MM, Goossens SMTA. COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy. Ultrasound Obstet Gynecol 2020;56:773-6. [PMID: 32853442 DOI: 10.1002/uog.22189] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 279 |
Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, Rimmelé T, Zarbock A, Bell S, Bihorac A, Cantaluppi V, Hoste E, Husain-Syed F, Germain MJ, Goldstein SL, Gupta S, Joannidis M, Kashani K, Koyner JL, Legrand M, Lumlertgul N, Mohan S, Pannu N, Peng Z, Perez-Fernandez XL, Pickkers P, Prowle J, Reis T, Srisawat N, Tolwani A, Vijayan A, Villa G, Yang L, Ronco C, Kellum JA. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 2020;16:747-64. [PMID: 33060844 DOI: 10.1038/s41581-020-00356-5] [Cited by in Crossref: 237] [Cited by in F6Publishing: 288] [Article Influence: 79.0] [Reference Citation Analysis]
|
| 280 |
Alharthy A, Faqihi F, Balhamar A, Memish ZA, Karakitsos D. Life-threatening COVID-19 presenting as stroke with antiphospholipid antibodies and low ADAMTS-13 activity, and the role of therapeutic plasma exchange: A case series. SAGE Open Med Case Rep 2020;8:2050313X20964089. [PMID: 33101686 DOI: 10.1177/2050313X20964089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 281 |
Alabyad D, Rangaraju S, Liu M, Imran R, Kempton CL, Sharifpour M, Auld SC, Gaddh M, Sniecinski R, Maier CL, Guarner J, Duncan A, Nahab F. Markers Of Coagulation And Hemostatic Activation Identify COVID-19 Patients At High Risk For Thrombotic Events, ICU Admission and Intubation.. [DOI: 10.1101/2020.10.04.20206540] [Reference Citation Analysis]
|
| 282 |
Ko CJ, Harigopal M, Gehlhausen JR, Bosenberg M, McNiff JM, Damsky W. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. J Cutan Pathol 2021;48:47-52. [PMID: 32895985 DOI: 10.1111/cup.13866] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 283 |
Bonjorno LP, Lopes MIF, Louzada Junior P, Oliveira RDRD. Imunopatologia induzida por COVID-19: avaliação da resposta imune inata e adaptativa. Rev Paul Reumatol 2020. [DOI: 10.46833/reumatologiasp.2020.19.3.6-11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 284 |
Ruzicka JA. Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease. Thromb Res 2020;196:257-9. [PMID: 32920296 DOI: 10.1016/j.thromres.2020.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 285 |
Sebuhyan M, Mirailles R, Crichi B, Frere C, Bonnin P, Bergeron-Lafaurie A, Denis B, Liegeon G, Peyrony O, Farge D; Saint-Louis CORE (COVID-19 RESEARCH) group. How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units. J Med Vasc 2020;45:334-43. [PMID: 33248536 DOI: 10.1016/j.jdmv.2020.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 286 |
Riva G, Nasillo V, Tagliafico E, Trenti T, Comoli P, Luppi M. COVID-19: more than a cytokine storm. Crit Care 2020;24:549. [PMID: 32887652 DOI: 10.1186/s13054-020-03267-w] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 287 |
Zhu C, Sun B, Zhang X, Zhang B. Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019. Front Pharmacol 2020;11:1327. [PMID: 32973534 DOI: 10.3389/fphar.2020.01327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 288 |
Carsetti A, Damiani E, Casarotta E, Scorcella C, Domizi R, Montomoli J, Gasparri F, Gabbanelli V, Pantanetti S, Carozza R, Adrario E, Donati A. Sublingual microcirculation in patients with SARS-CoV-2 undergoing veno-venous extracorporeal membrane oxygenation. Microvasc Res 2020;132:104064. [PMID: 32841626 DOI: 10.1016/j.mvr.2020.104064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 289 |
Martín-Rojas RM, Pérez-Rus G, Delgado-Pinos VE, Domingo-González A, Regalado-Artamendi I, Alba-Urdiales N, Demelo-Rodríguez P, Monsalvo S, Rodríguez-Macías G, Ballesteros M, Osorio-Prendes S, Díez-Martín JL, Pascual Izquierdo C. COVID-19 coagulopathy: An in-depth analysis of the coagulation system. Eur J Haematol 2020;105:741-50. [PMID: 32749010 DOI: 10.1111/ejh.13501] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 24.7] [Reference Citation Analysis]
|
| 290 |
Park J, Kim H, Kim SY, Kim Y, Lee J, Seong M, Han D. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.. [DOI: 10.1101/2020.08.18.255315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 291 |
Bayoumy AB, Ansari AR, De Abreu RA, Peters GJ, Mulder CJ. Multi-Drug Therapy Schedules for SARS-COV-2: Smart Repurposing of Old Drugs. Journal of Exploratory Research in Pharmacology 2020;000:1-2. [DOI: 10.14218/jerp.2020.00022] [Reference Citation Analysis]
|
| 292 |
Bidar F, Hékimian G, Martin-Toutain I, Lebreton G, Combes A, Frère C. Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports. J Artif Organs 2021;24:277-81. [PMID: 32789604 DOI: 10.1007/s10047-020-01203-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 293 |
Shovlin CL, Vizcaychipi MP. Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster. QJM 2020:hcaa241. [PMID: 32777054 DOI: 10.1093/qjmed/hcaa241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 294 |
Comer SP, Cullivan S, Szklanna PB, Weiss L, Cullen S, Kelliher S, Smolenski A, Moran N, Murphy C, Altaie H, Curran J, O’reilly K, Cotter AG, Marsh B, Gaine S, Mallon P, Mccullagh B, Ní Áinle F, Kevane B, Maguire PB. COVID-19 induces a hyperactive phenotype in circulating platelets.. [DOI: 10.1101/2020.07.24.20156240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
